Xencor

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.

About XNCR

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. 

CEO
Bassil I. Dahiyat
CEOBassil I. Dahiyat
Employees
250
Employees250
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1997
Founded1997
Employees
250
Employees250

XNCR Key Statistics

Market cap
783.74M
Market cap783.74M
Price-Earnings ratio
-3.03
Price-Earnings ratio-3.03
Dividend yield
Dividend yield
Average volume
783.87K
Average volume783.87K
High today
$11.24
High today$11.24
Low today
$10.29
Low today$10.29
Open price
$10.44
Open price$10.44
Volume
777.58K
Volume777.58K
52 Week high
$27.24
52 Week high$27.24
52 Week low
$7.16
52 Week low$7.16

XNCR News

TipRanks 1d
Xencor reports ‘positive’ interim results from XmAb942 volunteer study

Xencor (XNCR) announced positive interim results from its first-in-human study of XmAb942, a high-potency, extended half-life, investigational anti-TL1A antibod...

Simply Wall St 5d
Is Xencor A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonym...

Is Xencor A Risky Investment?

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
0%
Sell
8.3%

People also own

Based on the portfolios of people who own XNCR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.